These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10867545)

  • 1. Evaluation of changes in amino acid metabolism in pre-dialysis patients treated with erythropoietin.
    Nishikage H; Kosugi T; Danbara A; Yamamoto J; Matsuo S; Hotta N
    Nephron; 2000 Jul; 85(3):277-8. PubMed ID: 10867545
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
    Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
    Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of rhEPO therapy on the protein metabolism of hemodialysis patients with terminal renal insufficiency.
    Fischer C; Scigalla P; Park W; Becker H; Schiller R; Paust H; Broesicke H; Kessel M
    Contrib Nephrol; 1989; 76():250-6. PubMed ID: 2684526
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia.
    Rapoport I; Engelhardt I; Drung I; Holzhütter H; Schmidt G
    Biomed Biochim Acta; 1990; 49(2-3):S280-3. PubMed ID: 2386518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of amino acid metabolism during rhEPO therapy in hemodialysis patients results from a better oxygen availability.
    Riedel E; Hampl H
    Nephron; 1995; 69(2):196-7. PubMed ID: 7723917
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
    Meierhenrich R; Jedicke H; Voigt A; Lange H
    Clin Nephrol; 1996 Feb; 45(2):90-7. PubMed ID: 8846536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
    N Engl J Med; 1987 Jul; 317(4):249-51. PubMed ID: 3600716
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN; Stetsiuk EA; Lovchinskiĭ EV; Lebedev SV; Iarmolinskiĭ IS; Liakhov VV
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of anemia and secondary hyperparathyroidism with erythropoietin treatment in hemodialysis patients.
    Seyrek N; Paydas S; Sagliker Y
    Nephron; 1996; 73(2):338-9. PubMed ID: 8773378
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure.
    Maxwell AP
    Kidney Int; 2002 Aug; 62(2):720-9. PubMed ID: 12110039
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal insufficiency and erythropoietin].
    Takaku F
    Nihon Rinsho; 1974 Mar; 32(3):528-34. PubMed ID: 4603797
    [No Abstract]   [Full Text] [Related]  

  • 18. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of recombinant human erythropoietin in pregnancy.
    McGregor E; Stewart G; Junor BJ; Rodger RS
    Nephrol Dial Transplant; 1991; 6(4):292-3. PubMed ID: 1881584
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.